More articles from Sarcoidosis

Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study
Marios Rossides, Susanna Kullberg, Anders Eklund, Daniela Di Giuseppe, Johan Grunewald, Johan Askling, Elizabeth V. Arkema

European Respiratory Journal Sep 2020, 56 (3) 2000767; DOI: 10.1183/13993003.00767-2020
Atopobium and Fusobacterium as novel candidates for sarcoidosis-associated microbiota
Alexandra Zimmermann, Henrik Knecht, Robert Häsler, Gernot Zissel, Karoline I. Gaede, Sylvia Hofmann, Almut Nebel, Joachim Müller-Quernheim, Stefan Schreiber, Annegret Fischer

European Respiratory Journal Dec 2017, 50 (6) 1600746; DOI: 10.1183/13993003.00746-2016
Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976–2013
Patompong Ungprasert, Cynthia S. Crowson, Eric L. Matteson

European Respiratory Journal Feb 2017, 49 (2) 1601290; DOI: 10.1183/13993003.01290-2016
Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis
Yvan Jamilloux, Delphine Maucort-Boulch, Sébastien Kerever, Mathieu Gerfaud-Valentin, Christiane Broussolle, Mireille Eb, Dominique Valeyre, Pascal Seve

European Respiratory Journal Dec 2016, 48 (6) 1700-1709; DOI: 10.1183/13993003.00457-2016
Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden
Elizabeth V. Arkema, Johan Grunewald, Susanna Kullberg, Anders Eklund, Johan Askling

European Respiratory Journal Dec 2016, 48 (6) 1690-1699; DOI: 10.1183/13993003.00477-2016
Expanded lung T-bet⁺RORγT⁺ CD4⁺ T-cells in sarcoidosis patients with a favourable disease phenotype
Ylva Kaiser, Rico Lepzien, Susanna Kullberg, Anders Eklund, Anna Smed-Sörensen, Johan Grunewald

European Respiratory Journal Aug 2016, 48 (2) 484-494; DOI: 10.1183/13993003.00092-2016
^99mTc-anti-TNF-α antibody for the imaging of disease activity in pulmonary sarcoidosis
Roeland Vis, Gaurav Malviya, Alberto Signore, Jan C. Grutters, Bob Meek, Ewoudt M.W. van de Garde, Ruth G.M. Keijsers

European Respiratory Journal Apr 2016, 47 (4) 1198-1207; DOI: 10.1183/13993003.01352-2015
Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis
Adriane D.M. Vorselaars, Heleen A. Crommelin, Vera H.M. Deneer, Bob Meek, Anke M.E. Claessen, Ruth G.M. Keijsers, Coline H.M. van Moorsel, Jan C. Grutters

European Respiratory Journal Jul 2015, 46 (1) 175-185; DOI: 10.1183/09031936.00227014
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis
Marc A. Judson, Robert P. Baughman, Ulrich Costabel, Marjolein Drent, Kevin F. Gibson, Ganesh Raghu, Hidenobu Shigemitsu, Joseph B. Barney, Daniel A. Culver, Nabeel Y. Hamzeh, Marlies S. Wijsenbeek, Carlo Albera, Isham Huizar, Prasheen Agarwal, Carrie Brodmerkel, Rosemary Watt, Elliot S. Barnathan

European Respiratory Journal Nov 2014, 44 (5) 1296-1307; DOI: 10.1183/09031936.00000914
Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes
Robert Su, Michael M. Li, Nirav R. Bhakta, Owen D. Solberg, Eli P.B. Darnell, Joris Ramstein, Suresh Garudadri, Melissa Ho, Prescott G. Woodruff, Laura L. Koth

European Respiratory Journal Oct 2014, 44 (4) 985-993; DOI: 10.1183/09031936.00039714

Main menu

User menu

Search

More articles from Sarcoidosis

Pages

Contact us